Ryan Govender
Chief Executive Officer at TREATT PLC
Net worth: 719 $ as of 2024-03-30
Ryan Govender active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TREATT PLC | Director/Board Member | 2022-06-30 | - |
| Chief Executive Officer | 2023-12-31 | - | |
| Corporate Secretary | - | - | |
| Director of Finance/CFO | 2022-06-30 | 2023-12-31 | |
| Corporate Officer/Principal | 2022-05-22 | 2022-06-30 |
Career history of Ryan Govender
Former positions of Ryan Govender
| Companies | Position | Start | End |
|---|---|---|---|
SPI Pharma, Inc.
 SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - | - |
Statistics
International
| United Kingdom | 2 |
| United States | 2 |
Operational
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Process Industries | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TREATT PLC | Process Industries |
| Private companies | 1 |
|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |
- Stock Market
- Insiders
- Ryan Govender
- Experience